Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Phase I study of recombinant leukocyte A human interferon combined with BCNU in selected patients with advanced cancerE T Creagan, J S Kovach, H J Long, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasmsE T Creagan, A J Schutt, R L Richardson, et al.
American Journal of Clinical Oncology|October 1, 1984
Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.
Head & Neck Surgery|July 1, 1984
A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasmsE T Creagan, J N Ingle, A J Schutt, et al.
Cancer Treatment Reports|December 1, 1982
Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanomaE T Creagan, A J Schutt, D L Ahmann, et al.
Cancer|November 1, 1979
Pulmonary resection for metastatic nonosteogenic sarcomaE T Creagan, T R Fleming, J H Edmonson, et al.
Cancer|December 1, 1983
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancerE T Creagan, J E Woods, A J Schutt, et al.
American Journal of Clinical Oncology|June 1, 1990
Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanomaE T Creagan, D L Ahmann, A J Schutt, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Phase I study of recombinant leukocyte A human interferon combined with BCNU in selected patients with advanced cancerE T Creagan, J S Kovach, H J Long, et al.
American Journal of Clinical Oncology|August 1, 1993
Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasmsE T Creagan, A J Schutt, R L Richardson, et al.
American Journal of Clinical Oncology|October 1, 1984
Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.
Head & Neck Surgery|July 1, 1984
A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasmsE T Creagan, J N Ingle, A J Schutt, et al.
Cancer Treatment Reports|December 1, 1982
Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanomaE T Creagan, A J Schutt, D L Ahmann, et al.
Cancer|November 1, 1979
Pulmonary resection for metastatic nonosteogenic sarcomaE T Creagan, T R Fleming, J H Edmonson, et al.
Cancer|December 1, 1983
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancerE T Creagan, J E Woods, A J Schutt, et al.
American Journal of Clinical Oncology|June 1, 1990
Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.
Cancer Treatment Reports|June 1, 1982
Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanomaE T Creagan, D L Ahmann, A J Schutt, et al.
Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.
Pageof 12